Antu biological: no impact on production and operation, emergency measures have been launched
"The rainstorm in Zhengzhou has a little impact on employees' commuting. The company's production and operation are not affected for the time being, and there is no ponding," Fang ruikuanbin, director and Secretary of Antu biology, said in an interview with kechuangban daily on the 21st. The weather forecast says the heavy rain may end today. The company has launched emergency response measures, yesterday we all lived in the company did not go back According to the data, Antu biological office is located at 199 Jingkai 15th Street, Zhengzhou Economic and Technological Development Zone, Henan Province.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Yesterday 05:07 PM
· Healthcare
The main board of HKEx is the largest digital comprehensive service platform for the pharmaceutical industry outside the hospital in China
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Consumer Staples, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Healthcare, Financials
Services Provider Haixin Zhihui Raises CNY Hundreds of Mns in Series B Funding
Founded in January 2018, Haixin Zhihui is an artificial intelligence company focusing on the oncology field, it specializes in intelligent tumor diagnosis and treatment and has developed the first oncology intelligent diagnosis and treatment system in China.
Yesterday 04:04 PM
Briefing May 24, 2022 10:54 PM
· Healthcare
Glencore will settle the US and UK investigations for $1.5 billion.
Healthcare
China's Pharmaceutical Platform YSB Inc. Submits H. K. IPO Application
Pharmaceutical sales platform YSB Inc. has raised funds in multiple rounds since its establishment in 2015. The investors include DCM Ventures, H Capital, Green Pine Capital Partners, and Shanghai Fosun Pharmaceutical Group. According to the prospectus, the fund-raising via IPO is mainly used to build the online pharmaceutical platform, develop innovative business and R&D investments in data and AI.
Yesterday 04:01 PM
Briefing Oct 12, 2021 05:44 PM
· Healthcare
Nippon instruments: the profit in the first three quarters is expected to drop by 58% - 63%
Briefing Aug 20, 2021 09:48 AM
· Healthcare
Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%
See more
Read next
In-depth
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.